Scientists use advanced scanners to peek at Brain's chemical messengers

NCT ID NCT00109174

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses magnetic resonance spectroscopy (MRS) to measure how the brain processes glucose into key chemical messengers like glutamate and GABA. Researchers aim to improve the accuracy and reliability of MRS technology. The study involves 200 healthy adults aged 18-65 and focuses on refining imaging methods rather than testing a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could improve how doctors measure brain chemistry, helping future research on brain disorders.

What could go wrong

This is an early-stage observational study in healthy volunteers, not testing a treatment. It may not directly lead to new therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NORMAL PHYSIOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States